Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
(By Julie Appleby and Sydney Lupkin for Kaiser Health News) President Donald Trump wants to control spending on drugs. One
Read More
FDA
‘Right-to-try’ law intended to weaken the FDA, measure’s sponsor says in blunt remarks
(By Erin Mershon for ST A T) WASHINGTON — Sen. Ron Johnson, the author of the federal “right-to-try” law signed
Read MoreFDA taking new steps to address the root cause of drug shortages
The US Food and Drug Administration (FDA) said it has committed to taking new steps to address the root cause
Read MoreFDA’s innovation challenge
The Food and Drug Administration is accepting proposals from developers aimed at encouraging the development of medical devices or with
Read MoreRight To Try Act Poses Big Challenge For FDA
(By Michael D. Becker for NPR) In his first year as commissioner of the Food and Drug Administration, Scott Gottlieb
Read MoreDrugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions
(By Sydney Lupkin for Kaiser Health News) Makers of brand-name drugs called out by the Trump administration for potentially stalling
Read MoreFDA plans to speed path to approval for some gene therapies, starting with hemophilia
(By Ike Swetlitz for ST A T) WASHINGTON — The Food and Drug Administration will soon be alerting companies that
Read MoreFDA’s strategic priorities for 2018 is advancing digital health technologies
One of the priorities this year for the FDA is advancing digital health technologies. FDA’s Center for Devices and Radiological
Read MoreNew Type Of Drug To Prevent Migraines Heads To Market
(By Richard Harris for NPR) The Food Drug Administration has approved a first-of-its-kind drug that reduces the number of migraines
Read MoreRight-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says
(By Ike Swetlitz and Erin Mershon for ST A T) WHITE OAK, Md. — The House is set to take
Read More